Kempen Capital Management N.V. Abb Vie Inc. Transaction History

Kempen Capital Management N.V.

$9.59 Billion
Q3 2024

A detailed history of Kempen Capital Management N.V. transactions in Abb Vie Inc. stock. As of the latest transaction made, Kempen Capital Management N.V. holds 36,938 shares of ABBV stock, worth $6.65 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

36,938

Previous 37,574 1.69%

Holding current value

$6.65 Million

Previous $6.44 Million 13.19%

% of portfolio

0.08%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $104,202 - $126,773	-636 Reduced 1.69%	36,938 $7.29 Million
Q2 2024 Jul 24, 2024	BUY	$154.79 - $180.76 $785,249 - $916,995	5,073 Added 15.61%	37,574 $6.44 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $1.18 Million - $1.34 Million	7,369 Added 29.32%	32,501 $5.92 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $418,441 - $471,263	3,041 Added 13.77%	25,132 $3.89 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $2.7 Million - $3.12 Million	20,175 Added 1052.97%	22,091 $3.29 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $253,889 - $315,948	1,916 New	1,916 $258,000
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $1.89 Million - $2.1 Million	-17,941 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $243,985 - $268,598	2,385 Added 15.33%	17,941 $1.94 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $389,571 - $525,962	-4,840 Reduced 23.73%	15,556 $1.67 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $86,339 - $101,334	1,005 Added 5.18%	20,396 $1.79 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $346,599 - $463,802	4,724 Added 32.21%	19,391 $1.9 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $54,502 - $82,632	845 Added 6.11%	14,667 $1.12 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $955,938 - $1.2 Million	13,253 Added 2329.17%	13,822 $1.22 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $37,383 - $47,784	569 New	569 $41,000
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $28.4 Million - $31.1 Million	-316,850 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $22.1 Million - $28.3 Million	316,850	316,850 $28.2 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Kempen Capital Management N.V. with notifications on news.

Account

Kempen Capital Management N.V. Abb Vie Inc. Transaction History